Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.5200
+0.0011 (0.21%)
At close: Jun 24, 2026
Vaxart Market Cap
Vaxart has a market cap or net worth of $125.47 million as of June 24, 2026. Its market cap has increased by 38.39% in one year.
Market Cap
125.47M
Enterprise Value
76.65M
Revenue
255.61M
Ranking
n/a
PE Ratio
3.29
Stock Price
$0.52
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 125.47M, an increase of 107.91%. That is a compound annual growth rate of 9.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 125.47M | 50.93% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 362.42M |
| Silence Therapeutics | 343.39M |
| Glorywin Entertainment Group | 343.05M |
| Northwest Biotherapeutics | 315.44M |
| HST Global | 99.00M |
| NDT Pharmaceuticals | 95.27M |
| BioStem Technologies | 65.59M |
| Cell Source | 56.40M |